dvm360: FDA allocates funds for data collection and reporting on antimicrobial use in animals
With antimicrobial resistance (AMR) continuing to grow as a global threat, the United States Food and Drug Administration (FDA) recently announced it is granting cooperative agreement funds for 3 projects focused on the collection, analysis, and data reporting of antimicrobial use (AMU) in animals.